Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome

KJ Bosma, JF Lewis - Expert Opinion on Emerging Drugs, 2007 - Taylor & Francis
Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) is a life-threatening form of
respiratory failure that affects a heterogeneous population of critically ill patients. Although …

Evolution of treatments for patients with acute lung injury

AM Esper, GS Martin - Expert Opinion on Investigational Drugs, 2005 - Taylor & Francis
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are acute life-
threatening forms of hypoxemic respiratory failure. ALI/ARDS patients require intensive care …

Acute Respiratory Distress Syndrome: 30 Years Later?

O Lesur, Y Berthiaume, G Blaise, P Damas… - Canadian Respiratory …, 1999 - hindawi.com
Acute respiratory distress syndrome (ARDS) was first described about 30 years ago. Modern
definitions and statements have recently been proposed to describe ARDS accurately, but …

Pharmacotherapy for prevention and treatment of acute respiratory distress syndrome: current and experimental approaches

KJ Bosma, R Taneja, JF Lewis - Drugs, 2010 - Springer
The acute respiratory distress syndrome (ARDS) arises from direct and indirect injury to the
lungs and results in a life-threatening form of respiratory failure in a heterogeneous, critically …

Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome

CM Yamashita, JF Lewis - Expert Opinion on Emerging Drugs, 2012 - Taylor & Francis
In 2007, Bosma et. al provided a comprehensive review of emerging therapies for the acute
respiratory distress syndrome (ARDS), a condition which continues to carry a mortality rate …

Clinical developments for treating ARDS

G Martin, S Eaton - Expert Opinion on Investigational Drugs, 2002 - Taylor & Francis
Acute respiratory distress syndrome (ARDS), is characterised by capillary permeability and
pulmonary oedema formation and may complicate a variety of medical and surgical …

Acute respiratory distress syndrome: pharmacological treatment options in development

RD Hite, PE Morris - Drugs, 2001 - Springer
The acute respiratory distress syndrome (ARDS) is a clinical syndrome with primarily
supportive management options. Despite extensive basic and clinical investigations …

Emerging drugs for acute lung injury

D Impellizzeri, G Bruschetta, E Esposito… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: Acute respiratory distress syndromes (ARDS) are devastating disorders of
overwhelming pulmonary inflammation and hypoxemia, resulting in high morbidity and …

Surfactant therapy for acute lung injury/acute respiratory distress syndrome

JJ Haitsma, PJ Papadakos… - Current opinion in critical …, 2004 - journals.lww.com
Surfactant therapy for acute lung injury/acute respiratory d... : Current Opinion in Critical
Care Surfactant therapy for acute lung injury/acute respiratory distress syndrome : Current …

Pharmacotherapy of acute lung injury and acute respiratory distress syndrome

K Raghavendran, GS Pryhuber… - Current medicinal …, 2008 - ingentaconnect.com
Acute lung injury (ALI) and the acute respiratory distress syndrome (ARDS) are
characterized by rapid-onset respiratory failure following a variety of direct and indirect …